Compared with SG participants , participants in MORE evidenced significantly less stress arousal ( p = .034 ) and desire for opioids ( p = .027 ) , and were significantly more likely to no longer meet criteria for opioid use disorder immediately following treatment ( p = .05 ) ; however , these effects were not sustained at follow-up .